Condition created 2026-08-24 · updated 2026-08-27
colorectalanorectal-abscesscryptoglandularanorectaltextbookreferenceASCRS

Anorectal Abscess

First half of ASCRS Ch13 (third chapter of Part II, "Anorectal Disease"). Anorectal abscess and Anal Fistula (fistula-in-ano) are two stages of the same underlying cryptoglandular disease process, split here into separate pages as distinct clinically-coded entities (mirroring the Anal Fissure/Anal Stenosis split from ASCRS Ch12).

Epidemiology

True incidence is hard to pin down — many abscesses drain spontaneously or are incised/drained outside a colorectal practice (physician's office, ED, "surgicenter"), and many are misdiagnosed by patients and referring providers as "hemorrhoids." Documented incidence is 8.6–20 per 100,000 people; males affected more than females (2.4–3:1); mean presentation age 40. Cryptoglandular etiology accounts for 90% of anorectal abscesses; the remaining 10% arise from a range of other etiologies (Crohn's disease, obstetric injury, fissure, TB, sarcoid, HIV) — those etiologies are outside this chapter's scope and are covered in other pages (see Crohn Disease, Anal Fissure, Anorectal Sexually Transmitted Infections for HIV-anorectal-disease content).

Cryptoglandular pathophysiology

Anorectal glands originate at the dentate line, nestled between the anal papilla and the columns of Morgagni, and extend into the submucosal space, internal sphincter, intersphincteric space, and external sphincter to varying degrees (Eisenhammer's theory, popularized in the 1950s). When bacteria/debris become impacted within these glands, infection develops and tracks along the gland or along the path of least resistance from its origin — this determines both which anatomic space the resulting abscess occupies and, later, the course any resulting fistula takes.

Classification by anatomic space

Abscesses are classified by the potential space they occupy:

  • Perianal — most common subtype (42.7% of anorectal abscesses in one 1023-patient series).
  • Ischiorectal — 22.7%.
  • Intersphincteric — 21.4%. Often lacks external manifestations; presents instead as intense anal pain, often to the point the patient cannot tolerate a digital rectal exam without other clear pathology to explain the symptom.
  • Supralevator — 7.3%, least common. May arise from cephalad extension of a cryptoglandular process, but is more commonly associated with an intraabdominal process instead — diverticular disease, malignancy, or Crohn's disease. The route of drainage differs by origin (see Treatment below), making etiologic distinction clinically important, not just academic.
  • Horseshoe abscess — not a separate space but a distinct pattern: an abscess (most often ischiorectal in origin) that courses posteriorly through the deep postanal space to involve both ischiorectal spaces bilaterally. Other described horseshoe patterns arise from a perianal abscess extending through the superficial postanal space, an abscess extending through the anterior perianal space, or a supralevator abscess coursing through the posterior supralevator space.

Perianal and ischiorectal abscesses together represent the majority of presentations (65–80%).

Presentation and diagnosis

Perianal and ischiorectal abscesses typically present with perianal pain, swelling, and fluctuance, ± spontaneous drainage of purulent fluid — history and physical exam are generally sufficient for diagnosis. Intersphincteric abscesses lack external findings and present as intense anal pain with DRE intolerance and no other clear cause. Supralevator abscesses may mimic other symptoms (fissure, thrombosed hemorrhoid — see Hemorrhoids and Anal Fissure — STI, malignancy).

Imaging (CT, MRI, fistulogram, endoanal ultrasound) is not indicated for classic, uncomplicated presentations with a fluctuant area on exam. It may help with an unclear diagnosis (isolated intersphincteric abscess), or with complicating factors: malignancy, radiation, Crohn's disease, prior anorectal operations/trauma, or suspected complex abscess (horseshoe or supralevator extension).

Treatment

Expeditious incision and drainage is the primary treatment — not antibiotic therapy alone.

  • Perianal and ischiorectal abscesses: drained through the skin overlying the area of fluctuance. For a large cavity, the incision is placed over the part of the cavity closest to the anal verge, to avoid an unnecessarily long tract if a fistula subsequently develops (~one-third of acute anorectal abscesses persist as a fistula-in-ano).
  • Intersphincteric abscesses: require internal drainage at the dentate line via sphincterotomy if there's no external area of fluctuance — a special technical consideration to avoid iatrogenic injury.
  • Supralevator abscesses: route of drainage depends on origin, and getting this wrong risks iatrogenic creation of a suprasphincteric fistula. Those arising from an intraabdominal source should be drained transabdominally (interventional radiology) or transrectally; those from cephalad extension of a cryptoglandular process via the intersphincteric space should be drained transrectally; those from cephalad extension of an ischiorectal abscess should be drained transcutaneously.
  • Horseshoe abscesses: require both bilateral transcutaneous ischiorectal drainage and posterior drainage via division of the anococcygeal ligament to access the deep postanal space.
  • Setting: office/clinic incision and drainage is preferred over the OR when feasible, as it expedites sepsis control — facilitated by a local anesthetic wheal, needle decompression through the wheal, then a small incision. Deep/nonpalpable abscesses, those with tissue necrosis, or intolerant/inpatient patients are better managed in the OR.
  • Primary fistulotomy at the time of abscess drainage is controversial: some data show decreased abscess recurrence and fistula formation with primary fistulotomy, but this risks unnecessary sphincter division in patients who would not have gone on to develop a chronic fistula, and acute inflammation makes it harder to accurately judge degree of muscle involvement — raising incontinence risk. Not generally recommended to definitively manage the tract at the time of abscess drainage given this risk/benefit balance.

Post-drainage care

Packing the abscess cavity after transcutaneous drainage is not recommended — unpacked wounds are more manageable, with less pain and faster healing. A mushroom-tip or similar catheter can promote drainage and maintain the external opening in large/deep cavities. Warm water sitz baths (10–15 min, 2–3×/day) plus external gauze are otherwise sufficient wound care.

Post-drainage antibiotics

Traditionally reserved for extensive cellulitis, sepsis, or immunocompromise. When used, a broad-spectrum agent with gram-negative and anaerobic coverage plus gram-positive skin-flora coverage is adequate (augmentin alone; TMP-SMX alone; a quinolone + metronidazole; TMP-SMX or clindamycin if prior MRSA). Emerging data suggest post-drainage antibiotics may reduce fistula formation: one RCT (307 patients) found fistula formation fell from 30% (control) to 14.1% (ciprofloxacin + metronidazole, P<0.001); another found a drop from 48% to 17%; a subsequent meta-analysis found a 36% relative reduction in fistula formation with post-drainage antibiotics. However, these findings are not uniformly reproducible — other similar studies showed no protective effect — and given this inconclusive evidence, guidelines still recommend against routine post-drainage antibiotics. Bacterial culture at the time of drainage is not necessary without plans for post-drainage antibiotics, since the data wouldn't be actionable; if antibiotics are planned, culture may help guide selection (particularly with a history of MRSA).

  • Anal Fistula — the chronic sequela in ~30–35% of cryptoglandular abscesses; shares this page's underlying pathophysiology and anatomic-space framework.
  • Colorectal Anatomy & Embryology — the anal gland/crypt anatomy and perianal/intersphincteric/ submucous/ischioanal potential-space anatomy this page's classification builds directly on; closes that page's previously-flagged Ch13 gap.
  • Crohn Disease — a non-cryptoglandular etiology of anorectal abscess, out of this chapter's scope but covered on that page.
  • Hemorrhoids, Anal Fissure — differential diagnoses for perianal pain/swelling.
  • Pruritus Ani — abscess is listed among the anorectal-disorder causes of anal pruritus in that page's differential.
  • Anorectal Sexually Transmitted Infections — fuller HIV-anorectal-disease framework backing this page's HIV etiology mention.
  • Pediatric Colorectal Disorders — a distinctly different pediatric epidemiology (age/sex distribution, organism-sex association) and a genuinely unsettled operative-vs-nonoperative management literature, contrasting with this page's adult-focused approach.

Open items / gaps

  • Non-cryptoglandular abscess etiologies (Crohn's, obstetric injury, TB, sarcoid, HIV) are named but explicitly out of this chapter's scope — most already covered to varying depth elsewhere in the wiki (see Crohn Disease), but not comprehensively cross-referenced here.